Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11498950 Fusion molecules and IL-15 variants

Overview Structured Data Issues Contributors Activity

Is a

Patent attributes

Patent Applicant

Altor BioScience

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

Date of Patent

November 15, 2022

Patent Application Number

16659311

Date Filed

October 21, 2019

Patent Citations

US Patent 10537615 IL-15-based molecules and methods of use thereof

US Patent 10450359 IL-15 variants and uses thereof

US Patent 11168138 Anti-PDL1, IL-15 and TGF-beta receptor combination molecules

US Patent 10865230 Construction and characterization of multimeric IL-15-based molecules with CD3 binding domains

US Patent 10150805 Multimeric IL-15 soluble fusion molecules and methods of making and using same

US Patent 10358478 Multimeric IL-15 soluble fusion molecules and methods of making and using same

Patent Citations Received

US Patent 11925676 Method for treating neoplasia with an anti-CD38 antibody and an IL-15:IL-15R complex

0

Patent Primary Examiner

Bridget E Bunner

CPC Code

...

The instant invention provides soluble fusion protein complexes and IL-15 variants that have therapeutic and diagnostic use, and methods for making the proteins. The instant invention additionally provides methods of stimulating or suppressing immune responses in a mammal using the fusion protein complexes and IL-15 variants of the invention.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11498950 Fusion molecules and IL-15 variants

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool